YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Trasylol
Trasylol Gone for Good
May 15, 2008 | Parker Waichman Alonso LLP
Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart...
Trasylol Named in 78 Lawsuits, Bayer Says
Apr 28, 2008 | Parker Waichman Alonso LLP
Bayer AG has been hit with 78 lawsuits over the drug Trasylol. In November, Bayer suspended Trasylol sales after a Canadian study linked it to...
More Trasylol Studies -- One Previously Withheld by Bayer -- Confirm Death Risks
Feb 21, 2008 | Parker Waichman Alonso LLP
Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug. Trasylol,...
FDA Trasylol Failure Could Have Killed Thousands, Researcher Says
Feb 15, 2008 | Parker Waichman Alonso LLP
Trasylol, a defective drug manufactured by Bayer AG, may have killed 22,000 people before it was pulled from the market last year. Trasylol was...
Trasylol Drug Combo Linked to Deaths
Feb 12, 2008 | Parker Waichman Alonso LLP
A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate. According to British...
Trasylol Sales Suspended After Canadian Study Links Drug to Sudden Death Risk
Nov 26, 2007 | Parker Waichman Alonso LLP
Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a...
Trasylol Deaths Exceed 200, FDA Says
Nov 19, 2007 | Parker Waichman Alonso LLP
Trasylol, a defective drug made by Bayer AG, may have killed more than 200 people, according to the Food & Drug Administration (FDA). ...
Trasylol Pulled From World Market by Bayer AG
Nov 7, 2007 | Parker Waichman Alonso LLP
Trasylol, an anti-bleeding medication, was pulled from the market earlier this week following concerns that it put patients at a high risk of...
Trasylol to Undergo another FDA Safety Review After Canada Halts Clinical Trial
Oct 29, 2007 | Parker Waichman Alonso LLP
Trasylol will be the subject of yet another Food & Drug Administration (FDA) safety review, after a clinical trial involving the drug was halted...
Trasylol Clinical Trail Halted Due to Bleeding, Death Risk
Oct 25, 2007 | Parker Waichman Alonso LLP
A Trasylol clinical trial has been halted according to the Food & Drug Administration (FDA) because patients enrolled in the study who took...
Trasylol
